Neuland Laboratories to Showcase Strategy at Goldman Sachs CDMO Day

Neuland Laboratories is set to participate in the Goldman Sachs Global Healthcare CDMO Day in Singapore from September 23-25, 2026. The event will provide an opportunity for the company's management team to engage with institutional investors and analysts through both group and one-on-one meetings.

The engagement forms part of Neuland Laboratories' investor relations calendar for the quarter, as disclosed under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that the schedule and participant list remain subject to change based on exigencies involving participants or the company.

Neuland Laboratories' participation in the Goldman Sachs Global Healthcare CDMO Day may influence its valuation multiples relative to global peers in the coming quarter. The company's management is likely to highlight specific strategic initiatives or capacity expansion plans to attract long-term institutional capital during these meetings.